戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 which is characterized by pulmonary vascular dysmorphia.
2  use and abuse, dieting regimens, and muscle dysmorphia.
3 diac abnormalities, short stature and facial dysmorphia.
4 triad of periodic paralysis, arrhythmia, and dysmorphia.
5  vimentin is involved in cancer cell nuclear dysmorphia.
6 cluding a likely AAS use disorder and muscle dysmorphia.
7 neurodevelopmental syndrome with mild facial dysmorphia.
8 iagnostic distinction based on the degree of dysmorphia.
9 een reported to have mild to moderate facial dysmorphia.
10 tal heart disease, short stature, and facial dysmorphia.
11   The authors interviewed 24 men with muscle dysmorphia and 30 normal comparison weightlifters, recru
12 he apparent rise in disorders such as muscle dysmorphia and anabolic steroid abuse.
13 rinatal lethality and prevented craniofacial dysmorphia and cardiac defects.
14 easures, including marked symptoms of muscle dysmorphia and stronger endorsement of conventional male
15 e characterized by extremity anomalies, mild dysmorphia, and intellectual impairment caused by 3:1 me
16 n disorder, with short stature, craniofacial dysmorphia, and morphologic, histologic, echocardiograph
17 y will deeply phenotype cognition, behavior, dysmorphias, and neuromedical traits on an expected coho
18                                       Muscle dysmorphia appears to be a valid diagnostic entity, poss
19 s including cardiac abnormalities and facial dysmorphia but is not sufficient for tumor formation.
20 l defects such as growth delay, craniofacial dysmorphia, cardiac defects, and hematologic abnormaliti
21                                      Nuclear dysmorphia, characterized by crumpled or lobulated polym
22                              Men with muscle dysmorphia differ sharply from normal weightlifters, mos
23                          The men with muscle dysmorphia differed significantly from the normal compar
24  cancer A549 cells largely prevented nuclear dysmorphia during the epithelial-to-mesenchymal transiti
25 asures but showed greater symptoms of muscle dysmorphia (e.g., not allowing their bodies to be seen i
26                          The men with muscle dysmorphia frequently described shame, embarrassment, an
27 , including growth delay, distinctive facial dysmorphia, hematologic abnormalities, and cardiac defec
28            The mechanisms underlying nuclear dysmorphia in cancer remain poorly understood.
29 t not MC(T)LUVA was associated with vascular dysmorphia in lung explants.
30 rized by proportionate short stature, facial dysmorphia, increased risk of leukemia, and congenital h
31                                       Muscle dysmorphia is a form of body dysmorphic disorder in whic
32 Moreover, we found that VIF-mediated nuclear dysmorphia led to defects in DNA repair.
33              In low-income countries, Muscle Dysmorphia (MD) has only been investigated in adult sout
34 individuals with DGS/VCFS, including: facial dysmorphia, mental retardation, long slender digits and
35 at unrestrained contractility causes nuclear dysmorphia, nuclear envelope rupture and genome instabil
36  Seven men (58%) met the criteria for muscle dysmorphia on screening.
37 ation) to phase III (inner retinal thinning, dysmorphia, pigment epithelium infiltration) remodeling.
38 -related attitudes and behaviors, and muscle dysmorphia ("reverse anorexia nervosa").
39  scores on a retrospective adolescent muscle-dysmorphia scale, the hazard ratio was 1.5 (.84, 2.6); f
40 velopmental disorder characterized by facial dysmorphia, short stature, cardiac defects, and skeletal
41 tic kidneys (pkd1 and pkd2) and craniofacial dysmorphia (six1).
42 n 3BP2, which is mutated in the craniofacial dysmorphia syndrome cherubism.
43 se number of phenotypes, ranging from subtle dysmorphia to viability.
44 velopmental disorder characterized by facial dysmorphia, upper limb malformations, growth and cogniti
45 velopmental disorder characterized by facial dysmorphia, upper-extremity malformations, hirsutism, ca
46  a novel role of VIFs in cancer cell nuclear dysmorphia, which is associated with genome instability.